Daxor Corporation.
DXR.US | Manufacture of medical and dental instruments and supplies
Daxor Corporation is a biotechnology and medical device company focused on blood volume measurement technology. It develops, manufactures, and markets the BVA-100 (Blood Volume Analyzer), a diagnostic tool used to measure a patient's blood volume. The BVA-100 is used in a variety of clinical setting...Show More
Better Health for All
20
Daxor's BVA-100 is an FDA-cleared diagnostic blood test, the only one of its kind, providing 98% accurate, objective quantification of blood volume.
1
The company's entire business is devoted to health improvement through this technology. Over 75,000+ tests have been performed at leading U.S. hospitals.
2
BVA-guided care has been shown to reduce patient mortality by over 82% and readmissions by 56%, and decrease hospital length of stay by 55% or 2.6 days.
3
The BVA test is by prescription and adult use only, with contraindications for pregnant patients or those with iodine allergies.
4
The BVA-100 blood test is described as inexpensive and objective, and is reimbursed with CPT & APC codes in outpatient and inpatient settings.
5
Daxor is developing analyzers for combat casualty care with the U.S. Department of Defense, having received over $7 million in government contract awards for next-generation BVA systems.
6
The company also has ongoing trials in heart failure treatment with NIH support.
7
The BVA-100 is integrated with Electronic Health Records.
8
A multi-center clinical trial is being initiated with two Veterans Affairs Medical Centers to evaluate BVA-guided management of acute decompensated heart failure in a vulnerable population.
9
Fair Money & Economic Opportunity
0
Daxor Corporation is a biotechnology and medical device company that manufactures and markets a diagnostic blood test (BVA-100) and related services.
1
The company's core business does not involve lending, insuring, moving, or storing money, nor does it offer financial products or services to consumers or businesses. Therefore, the KPIs under the 'Fair Money & Economic Opportunity' value, which are designed to assess financial institutions and their impact on economic opportunity through financial products, are not applicable to Daxor Corporation. The provided articles contain no evidence of Daxor engaging in any activities related to financial services, consumer credit, or financial inclusion initiatives.
2
For the KPI 'profit_reinvestment', no evidence was found regarding reinvestment in community finance or profit-sharing with underserved communities, leading to its omission.
3
Fair Pay & Worker Respect
0
The provided articles indicate no mention of regulatory actions, violations, fines, or compliance issues related to labor laws or human rights.
1
While some articles list salary ranges for specific roles and employee feedback on pay, management, and benefits, there is no quantitative data available for living wage coverage, CEO to median employee pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, employee turnover rate, insecure contract share, or health insurance coverage.
2
Fair Trade & Ethical Sourcing
0
No evidence available to assess Daxor Corporation on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete evidence was found in the provided articles to assess Daxor Corporation against any of the KPIs for the 'Honest & Fair Business' value. Information regarding regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policies, or third-party verification was not mentioned or could not be extracted.
1
Kind to Animals
10
Daxor Corporation is explicitly identified by a third-party source as having 'No Animal Exploitation'.
1
The company's core business involves developing and manufacturing a blood volume analyzer for human use, which does not involve animal inputs or agriculture.
2
This indicates a global corporate ban on all animal testing across every product category, and that no live animals are used in testing.
No War, No Weapons
0
No evidence available to assess Daxor Corporation on No War, No Weapons.
Planet-Friendly Business
0
No quantitative data related to Daxor Corporation's planet-friendly business practices or sustainability performance was provided in the available articles.
1
The articles explicitly state that no sustainability data is available for DXR.US at this time.
2
Respect for Cultures & Communities
0
No specific, concrete data points related to Daxor Corporation (DXR.US) or the ethical value 'Respect for Cultures & Communities' were found in the provided articles.
1
The articles either discuss general topics or indicate no relevant data was found for the company.
Safe & Smart Tech
0
Daxor's privacy policy, last updated October 17, 2023, outlines that users have rights to access, correct, and delete their personal data.
1
It also provides the right to opt-out of the sale or sharing of personal data, which aligns with industry-standard user privacy controls.
2
The company details its compliance with CCPA/CPRA, including categories of collected data, sources, and uses, and references other laws like CalOPPA, HIPAA, and GLBA, indicating good compliance with applicable regulations.
3
Zero Waste & Sustainable Products
-30
Daxor's BVA-200 device demonstrates improved material efficiency by requiring 3 mL of blood for phlebotomy, a 50% reduction compared to the 6 mL needed for the predicate device.
1
For hazardous waste management, the BVA-200 uses I-131 as a tracer, with the dose limited to a maximum of 25 microcuries (μCi), resulting in an effective dose equivalent (EDE) comparable to annual natural radiation exposure.
2
Nuclear medical technicians are monitored for radiation exposure, which is a very small fraction of patient exposure.
3
The BVA-200 incorporates a Mil Spec rugged tablet computer, suggesting enhanced product durability.
4
Furthermore, the FDA's 510(k) premarket notification for the BVA-200, dated August 4, 2025, does not mention any waste disposal violations or citations for Daxor Corporation, indicating strong compliance with regulations.
5